A Canadian population-based observational cohort study of alpha and beta-thalassemia syndromes in pregnancy
Acta Haematologica · 29.10.2026
DOI: 10.1159/aha/abkag021 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Acta Haematologica, online erschienen am 29.10.2026. Verfasst von Nathalie Auger und 5 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Introduction
Beta-thalassemia can adversely affect pregnancy, but the impact of alpha-thalassemia is less studied. We assessed whether patients with symptomatic alpha-thalassemia have similar pregnancy outcomes as patients with symptomatic beta-thalassemia.
Methods
We conducted a population-based retrospective cohort study of 1,324,488 pregnancies in Quebec, Canada, between 2006 and 2022. The exposures were maternal symptomatic alpha-thalassemia, symptomatic beta-thalassemia, thalassemia trait, and other thalassemia syndromes. Primary outcomes were severe maternal morbidity, preterm birth, preeclampsia, and other pregnancy complications. We used log-binomial regression models to estimate adjusted risk ratios (RR) and 95% confidence intervals (CI) for the association between each thalassemia and adverse pregnancy outcomes.
Results
In total, 825 patients had symptomatic alpha-thalassemia, 681 symptomatic beta-thalassemia, 1,749 thalassemia trait, and 2,377 other thalassemia syndromes. Compared with no thalassemia, alpha-thalassemia (RR 3.05; 95% CI: 2.36-3.94) and beta-thalassemia (RR 2.52; 95% CI: 1.84-3.45) were associated with a greater risk of severe maternal morbidity. However, alpha-thalassemia was additionally associated with preterm birth (RR 1.45; 95% CI: 1.16-1.82), preeclampsia (RR 1.67; 95% CI: 1.27-2.20), and gestational diabetes (RR 1.79; 95% CI: 1.52-2.09). Beta-thalassemia was not associated with these outcomes, and associations were weak for thalassemia trait and other thalassemias.
Conclusion
The findings suggest that symptomatic alpha-thalassemia is associated with a wider range of pregnancy complications than symptomatic beta-thalassemia and other thalassemia syndromes. However, symptomatic alpha and beta-thalassemia are both associated with severe maternal morbidity.
Zitieren
APA
Auger, N., Dubois, D., Wei, S. Q., Ayoub, A., Healy-Profitós, J., & Côté-Corriveau, G. (2026). A Canadian population-based observational cohort study of alpha and beta-thalassemia syndromes in pregnancy. Acta Haematologica. https://doi.org/10.1159/aha/abkag021
Vancouver
Auger N, Dubois D, Wei SQ, Ayoub A, Healy-Profitós J, Côté-Corriveau G. A Canadian population-based observational cohort study of alpha and beta-thalassemia syndromes in pregnancy. Acta Haematologica. 2026. doi:10.1159/aha/abkag021
BibTeX
@article{Auger2026,
author = {Auger, Nathalie and Dubois, Delphine and Wei, Shu Qin and Ayoub, Aimina and Healy-Profitós, Jessica and Côté-Corriveau, Gabriel},
title = {A Canadian population-based observational cohort study of alpha and beta-thalassemia syndromes in pregnancy},
journal = {Acta Haematologica},
year = {2026},
doi = {10.1159/aha/abkag021}
}
EUVIMED